Oral estradiol and dydrogesterone combination therapy in postmenopausal women: Review of efficacy and safety-Reference-Cited by-同舟云学术

Oral estradiol and dydrogesterone combination therapy in postmenopausal women: Review of efficacy and safety

Published:2013-09 Issue:1 Volume:76 Page:10-21
ISSN:0378-5122
Container-title:Maturitas
language:en
Short-container-title:Maturitas

Author:

Stevenson John C.,Panay Nicholas,Pexman-Fieth Claire

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,General Biochemistry, Genetics and Molecular Biology

Reference84 articles.

1. Oral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushes;Maclennan;The Cochrane Database of Systematic Reviews,2004

2. Updated IMS recommendations on postmenopausal hormone therapy and preventive strategies for midlife health;Sturdee;Climacteric,2011

3. Oral ultra-low dose continuous combined hormone replacement therapy with 0.5mg 17beta-oestradiol and 2.5mg dydrogesterone for the treatment of vasomotor symptoms: results from a double-blind, controlled study;Stevenson;Maturitas,2010

4. Classification and pharmacology of progestins;Schindler;Maturitas,2003

5. Use of dydrogesterone in hormone replacement therapy;Mueck;Maturitas,2009

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical efficacy of gamma-oryzanol combined with Femoston for perimenopausal syndrome;World Journal of Clinical Cases;2024-08-06

2. The association of menopausal hormone levels with progression-related biomarkers in multiple sclerosis;Multiple Sclerosis and Related Disorders;2024-05

3. Menopausal symptoms and hormone therapy in women with multiple sclerosis: A baseline-controlled study;Multiple Sclerosis and Related Disorders;2022-11

4. Pulmonary embolism in menopausal hormone therapy: a population-based register study;Climacteric;2022-10-11

5. Ultra-low-dose estradiol and dydrogesterone: a phase III study for vasomotor symptoms in China;Climacteric;2021-08-17